Related Experiment Video
Updated: Aug 24, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Transfection of human mutated K-ras in mouse NIH-3T3 cells is associated with increased cloning efficiency and DNA
1Laboratory of Biophysics and Cytometry, National Institute for Cancer Research (I.S.T.), Genoa, Italy.
Abstract:
The aim of the study was to test the hypothesis that a human mutated K-ras protein induces abnormalities in mitosis and development of sub-clones characterized by changes in DNA ploidy and proliferation. For this purpose, we used control and NIH-3T3 mouse cells transfected with the human codon 12 G-C-mutated K-ras oncogene. We found that abnormal mitoses, mainly characterized by lagging chromosomes in prometaphase or anaphase, had a significantly higher frequency in transfected cells than in control cells. The generation of sub-clones was screened by limiting-dilution experiments followed by cell expansion. Cloning efficiency was much higher for the K-ras transfected cells with 858/2112 (41%) successful sub-clones than for control, which provided 564/2592 (22%) sub-clones. DNA flow cytometry of 4.6-diamidino-2-phenilindole-2-hydrochloride-stained nuclei from randomly selected sub-clones was performed in order to evaluate DNA index and S-phase fraction values. We found 9 out of 100 DNA aneuploid sub-clones generated by the K-ras-transfected cells vs. 1 out of 100 for the controls. Overall, our data indicate that high expression of the mutationally activated human K-ras product in NIH-3T3 cells was associated with abnormal mitoses, increase of cloning efficiency and DNA aneuploidization.
Insights
A mutated human K-ras oncogene in mouse cells caused abnormal cell division and increased the rate of sub-clone development. These K-ras-driven sub-clones showed higher cloning efficiency and DNA aneuploidy, indicating genomic instability.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The K-ras oncogene plays a critical role in cell signaling pathways.
- Mutations in K-ras are frequently observed in various human cancers.
- Understanding the downstream effects of mutated K-ras is crucial for cancer research.
Purpose of the Study:
- To investigate if a mutated human K-ras protein induces mitotic abnormalities and sub-clone development.
- To determine if these sub-clones exhibit changes in DNA ploidy and proliferation.
- To assess the impact of activated K-ras on genomic stability.
Main Methods:
- NIH-3T3 mouse cells were transfected with a mutated human K-ras oncogene (codon 12 G-C).
- Abnormal mitoses were quantified by observing chromosome behavior during cell division.
- Sub-clone generation was assessed using limiting-dilution experiments and cloning efficiency.
- DNA content and cell cycle phase distribution were analyzed by flow cytometry.
Main Results:
- Transfected cells showed a significantly higher frequency of abnormal mitoses, including lagging chromosomes.
- K-ras-transfected cells exhibited a markedly increased cloning efficiency (41%) compared to control cells (22%).
- A higher proportion of DNA aneuploid sub-clones (9%) were generated from K-ras-transfected cells versus control cells (1%).
Conclusions:
- High expression of the activated human K-ras protein in NIH-3T3 cells is linked to mitotic abnormalities.
- Mutated K-ras promotes increased cloning efficiency and contributes to DNA aneuploidization.
- These findings suggest that activated K-ras can drive genomic instability and sub-clone evolution.
Related Concept Videos
In-vitro Mutagenesis
The Ras Gene
Ras is a superfamily...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

